Your browser doesn't support javascript.
loading
The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction.
Verma, Aradhana; Fonarow, Gregg C; Hsu, Jeffrey J; Jackevicius, Cynthia A; Mody, Freny Vaghaiwalla; Amidi, Omid; Goldberg, Sarah; Upparapalli, Deepti; Theodoropoulos, Kleanthis; Gregorio, Stephanie; Chang, Donald S; Bostrom, Kristina; Althouse, Andrew D; Ziaeian, Boback.
Afiliação
  • Verma A; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
  • Fonarow GC; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
  • Hsu JJ; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
  • Jackevicius CA; Department of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, CA, Department of Pharmacy, VA Greater Los Angeles Healthcare System, ICES, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
  • Mody FV; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
  • Amidi O; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
  • Goldberg S; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
  • Upparapalli D; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
  • Theodoropoulos K; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
  • Gregorio S; Department of Pharmacy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
  • Chang DS; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
  • Bostrom K; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
  • Althouse AD; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
  • Ziaeian B; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America. Electronic address: BZiaeian@mednet.ucla.edu.
Contemp Clin Trials ; 120: 106895, 2022 09.
Article em En | MEDLINE | ID: mdl-36028192
ABSTRACT

BACKGROUND:

Gaps in the receipt and dosing of guideline-directed medical therapy (GDMT) persist for patients with heart failure with reduced ejection fraction (HFrEF) [1]. In 2020, the Veterans Affairs (VA) developed a heart failure (HF) specific population dashboard to monitor care quality and performance on standard HFrEF performance measures [2].

METHODS:

The Dashboard Activated Services and Telehealth for HF (DASH-HF) study is a pragmatic randomized quality improvement study designed to evaluate the utility of proactive population management clinics using the VA's HF dashboard to optimize GDMT for patients with HFrEF. Panel management telemedicine clinics incorporated multidisciplinary clinicians to perform chart review and impromptu telephone encounters to evaluate current HFrEF management and opportunities to optimize GDMT. The study will evaluate the efficacy of proactive panel management to usual care at 6 months as quantified by the GDMT optimization potential score. Secondary outcomes include hospitalizations, mortality, and clinician time per intervention. The study completed enrollment and randomization of 300 participants. The intervention was performed from September to December 2021.

CONCLUSION:

DASH-HF will contribute to the literature by evaluating use of the existing VA dashboard to identify HF patients with the lowest adherence to GDMT and proactively target this group for the intervention. REGISTRATION https//clinicaltrials.gov/. Unique identifier NCT05001165.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article